BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2019
View Archived Issues
TNFR2 is yang to TNFR1's yin
Read More
IL-13Rlalpha2 as a therapeutic target in inflammatory bowel disease
Read More
Adropin is correlated with erectile dysfunction in coronary artery disease patients
Read More
Fast skeletal muscle troponin activators can counter skeletal muscle fatigue
Read More
Triple kinase inhibitor IBL-302 shows promising activity in preclinical models of neuroblastoma
Read More
New sialyltransferase inhibitors synthesized at Radboud Universiteit Nijmegen
Read More
InnoCare Pharma patents indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Initiator Pharma provides an update on IPED-2015 and IP-2018 development
Read More
Anti-LAG-3 fully human innovative antibody LBL-007 receives clinical approval
Read More
Decrease in tumor biomarkers seen in AIVITA's phase II study in patients with glioblastoma
Read More
Gritstone Oncology initiates phase I/II study of neoantigen-based therapeutic cancer vaccine
Read More
Positive topline results presented from ELIPSE HoFH phase III study of evinacumab
Read More
Themis Bioscience recruiting participants in phase I study of MV-ZIKA-RSP vaccine
Read More
H3R inverse agonist LML-134 demonstrates rapid brain penetration and fast kinetic profile
Read More
Pharmacokinetics and safety data presented from phase I study of EA-230
Read More
Sunshine Lake Pharma discovers sodium/glucose cotransporter 1 inhibitors
Read More
New dopamine D3 receptor antagonists synthesized at Shionogi
Read More
Cadila Healthcare identifies bacterial DNA topoisomerase II inhibitors
Read More
FDA approves new drug combination for highly drug-resistant tuberculosis
Read More
Rozlytrek approved by FDA or two new cancer indications
Read More
CARB-X awards funding to IBT to expand development of its IBT-V02 vaccine
Read More
Helmholtz Zentrum Munchen, Phio to identify new targets based on sd-rxRNA platform
Read More
CytoDyn provides update on its HIV dose-escalating monotherapy trial of leronlimab
Read More
Soligenix awarded grant to evaluate SGX-942 in pediatric indications
Read More
In dopamine D1 receptor combo, ghrelin is resurrected as Alzheimer's target
Read More